Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Guide
2026-09-03
Build sensitive human IgG detection workflows across immunofluorescence, tissue staining, flow cytometry, and ELISA with a single Cy3 conjugated secondary antibody. This guide connects practical signal optimization with antibody-characterization strategies inspired by orthopoxvirus therapeutic research.
-
Boc-D-FMK Workflows for Apoptosis Research
2026-09-02
Boc-D-FMK helps separate caspase-dependent cell death from upstream inflammatory signaling in cell and animal models. This practical guide combines treatment design, orthogonal readouts, assay controls, and troubleshooting for apoptosis research, renal endothelial inflammation, and hepatocyte injury studies.
-
Inducing Right Ventricular-Like Cardiomyocytes
2026-09-02
Saito et al. developed a modified GiWi differentiation strategy that shifts human pluripotent stem cell cardiac progenitors toward an anterior second heart field-like state and produces right ventricular-like cardiomyocytes. The work links developmental heart-field patterning with chamber-specific gene expression and functional phenotypes, providing a practical framework for right ventricular disease modeling.
-
SAR131675: Selective VEGFR-3 Inhibitor
2026-09-01
SAR131675 is a selective, ATP-competitive VEGFR-3 inhibitor with nanomolar biochemical and cellular activity. Preclinical studies support its use as an anti-lymphangiogenic agent and research tool in tumor and metabolic fibrosis models, but development was discontinued after adverse metabolic effects.
-
Acetoacetic acid sodium salt Workflows
2026-09-01
Build controlled ketone-body perturbation experiments with Acetoacetic acid sodium salt, from fresh aqueous stocks to orthogonal metabolic readouts. The workflow emphasizes dose, osmolarity, sample integrity, and the isotope-standardization lessons that make energy metabolism research more reproducible.
-
AS1842856 Foxo1 Inhibitor: Assay Reliability
2026-08-31
A scenario-based guide to using AS1842856 Foxo1 Inhibitor in viability, proliferation, gluconeogenesis, and autophagy studies. It explains how SKU B8219 supports mechanism-focused controls, formulation consistency, and cautious interpretation across hepatic and mesenchymal stem-cell models.
-
5-EdU for S Phase DNA Synthesis Detection
2026-08-31
5-Ethynyl-2'-deoxyuridine (5-EdU) enables rapid, sensitive labeling of newly synthesized DNA without the DNA denaturation required for BrdU assays. Its click-chemistry readout supports microscopy, flow cytometry, developmental birth dating, tumor growth research, and tissue regeneration studies while preserving morphology and antigen accessibility.
-
Sulfo-Cy3 azide for Aqueous Bioconjugation
2026-08-30
Sulfo-Cy3 azide is a water-soluble bioconjugation reagent for Click Chemistry fluorescent labeling of alkyne-bearing biomolecules. Its reported 563 nm excitation maximum, 584 nm emission maximum, and 162,000 M⁻¹cm⁻¹ extinction coefficient support bright fluorescence in aqueous labeling workflows.
-
Trichostatin A: From Epigenetic Probe to Translation
2026-08-29
Trichostatin A (TSA) is more than a histone deacetylase inhibitor: it is a mechanistic probe for connecting chromatin state, cell-cycle control, differentiation, and breast cancer heterogeneity. This thought-leadership perspective explains how to use TSA strategically in cancer research, with guidance on experimental design, product handling, and translational interpretation.
-
O6-Benzylguanine: A Translational MGMT Strategy
2026-08-28
O6-Benzylguanine offers a mechanism-proximal way to interrogate MGMT-driven resistance. This thought-leadership perspective connects irreversible MGMT inhibition with alkylator sensitization, recurrent glioma biology, assay design, and translational decision-making.
-
L. plantarum P101 Activates AMPK in Alcoholic Steatosis
2026-08-28
The reference study combines a short-term ethanol-plus-binge mouse model with pharmacological AMPK inhibition, gut microbiota profiling, and serum metabolomics to examine how Lactiplantibacillus plantarum P101 limits hepatic lipid accumulation. Its findings support AMPK activation as an important mediator of the probiotic response while identifying microbiota shifts and stercobilinogen as candidate correlates for future mechanistic studies.
-
2'-O-Methyladenosine: Assay Workflow Guide
2026-08-27
Build more reliable RNA modification and purine metabolite assays with 2'-O-Methyladenosine as a defined nucleoside standard, treatment probe, or analytical reference. This guide connects matrix-aware UHPLC–MS/MS preparation with cell-based assays for nucleoside transport, while separating practical starting conditions from literature-backed performance.
-
sEV CD147 Links HCC Diagnosis to Angiogenesis
2026-08-27
Huang et al. identify CD147-positive small extracellular vesicles as a candidate circulating marker of hepatocellular carcinoma and show that these vesicles actively promote endothelial angiogenic behavior. The study connects a liquid-biopsy signal with a PI3K/Akt–VEGFA mechanism, providing a useful framework for biomarker validation and pathway-focused experimentation.
-
MK 0893: Glucagon Receptor Antagonist Workflow
2026-08-26
MK 0893 combines nanomolar GCGR potency with reversible, allosteric control, making it useful for both receptor pharmacology and glucose-metabolism studies. This workflow connects cAMP assays in engineered cells with in vivo glucose excursion reduction in hGCGR mice while emphasizing solubility, selectivity, and exposure controls.
-
Sulfo-Cy3 Azide for Neurogenetic Mapping
2026-08-26
Translational neurobiology increasingly depends on connecting developmental timing with spatially resolved molecular identity. This thought-leadership article examines how Sulfo-Cy3 azide, a water-soluble bioconjugation reagent, could support follow-up studies of Nurr1-positive claustrum and lateral cortical neurons while distinguishing validated evidence from forward-looking workflow recommendations.